High fraction of silent recombination in a finite population two-locus neutral birth-death-mutation model
Akiva Bruno Melka, Yoram Louzoun

TL;DR
This paper demonstrates that in finite populations, most recombination events are silent and do not produce new haplotypes, leading to a need for revised estimates of haplotype diversity that account for silent recombination.
Contribution
It introduces a model showing silent recombination's prevalence in finite populations and proposes more accurate haplotype estimates considering this effect.
Findings
Silent recombination is common in finite populations.
Haplotype diversity grows slower than predicted by infinite site models.
Current recombination rate estimates in HLA are underestimated.
Abstract
A precise estimate of allele and haplotype polymorphism is of great interest in theoretical population genetics, but also has practical applications, such as bone marrow registries management. Allele polymorphism is driven mainly by point mutations, while haplotype polymorphism is also affected by recombination. Current estimates treat recombination as mutations in an infinite site model. We here show that even in the simple case of two loci in a haploid individual, for a finite population, most recombination events produce existing haplotypes, and as such are silent. Silent recombination considerably reduces the total number of haplotypes expected from the infinite site model for populations that are not much larger than one over the mutation rate. Moreover, in contrast with mutations, the number of haplotypes does not grow linearly with the population size. We hence propose a more…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsT-cell and B-cell Immunology · Renal Transplantation Outcomes and Treatments · Monoclonal and Polyclonal Antibodies Research
